HCV prevalence and predominant genotype in IV drug users
Hepatitis C virus (HCV) causes 308000 deaths due to liver cancer and 758000 deaths due to cirrhosis every year. Almost 170 million people have HCV infection around the world. Information regarding this virus helps us to determine the prevalence of other hepatitis C genotypes in population, especiall...
Main Authors: | Asad Andalibalshohada, Seyed Abdolrahim Rezaii, Farshid Abedi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2014-07-01
|
Series: | Reviews in Clinical Medicine |
Online Access: | http://rcm.mums.ac.ir/pdf_3154_9d47b46007db6706af8a9c9c899e6dce.html |
Similar Items
-
Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon.
by: Angélique Ndjoyi-Mbiguino, et al.
Published: (2018-01-01) -
Molecular Epidemiology of HCV Genotypes among Injection Drug Users in Taiwan
by: Huang-Jie Lin, et al.
Published: (2007) -
Molecular Epidemiology of HCV Genotypes Among Injection Drug Users in Taiwan
by: Yuan-Ming Lee, et al.
Published: (2010) -
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
by: Marzieh Jamalidoust, et al.
Published: (2017-07-01) -
Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy
by: Laura Camoni, et al.
Published: (2010-03-01)